Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
13.95
-0.19 (-1.34%)
Sep 10, 2026, 2:10 PM CST

SHE:002393 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,2561,5381,6391,9891,7931,652
Short-Term Investments
52.75-156.9470.72--
Trading Asset Securities
1,0411,020573.36160.54200.32-
Cash & Short-Term Investments
2,3502,5582,3692,2201,9941,652
Cash Growth
11.42%7.97%6.71%11.37%20.69%5.80%
Accounts Receivable
463.08408.91427.03312.51387.99414
Other Receivables
89.81126.43.214.410.877.43
Receivables
552.89535.32430.24316.91398.86421.43
Inventory
247.93215.11224.37176.28199.15228.78
Other Current Assets
20.6721.0735.81105.1133.7854.32
Total Current Assets
3,1713,3303,0602,8192,6252,356
Property, Plant & Equipment
943.54967.81,020976.481,0301,137
Long-Term Investments
881.62932.192.77194.051,4311,500
Goodwill
70.1770.3670.72---
Other Intangible Assets
137.96141.35184.06124.86135.49144.22
Long-Term Deferred Tax Assets
74.973.6743.839.4733.7116.31
Long-Term Deferred Charges
3.593.950.92---
Other Long-Term Assets
65.3265.481,3131,62735.9837.49
Total Assets
5,3485,5845,7865,7815,2915,191

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
103.76130.57135.8490.36146.3890.49
Accrued Expenses
219.91290.29290.83251.39297.23228.97
Short-Term Debt
6.6537.9639.7928.639.2928.14
Current Portion of Leases
3.032.992.840.870.420.4
Current Income Taxes Payable
16.4611.5711.7214.612.225.79
Current Unearned Revenue
20.1423.443414.9430.5411.29
Other Current Liabilities
295.91264.9231.5225.5203.9187.4
Total Current Liabilities
665.86761.73746.53626.27729.98552.47
Long-Term Leases
3.264.548.383.955.376.2
Long-Term Unearned Revenue
34.7432.9728.5127.9331.8331.68
Pension & Post-Retirement Benefits
10.3410.341111.3511.2811.31
Long-Term Deferred Tax Liabilities
106.89107.4181.01204.09162.04178.77
Other Long-Term Liabilities
7.896.8710.113.581.16-
Total Liabilities
828.99923.86985.54877.17941.66780.42

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
308.29257.59257.9184.28183.99182.45
Additional Paid-In Capital
1,5731,6221,6521,7211,7121,692
Retained Earnings
2,1152,2691,9421,8571,5511,512
Treasury Stock
-73.99-85.77-61.05-24.09-21.01-
Comprehensive Income & Other
564.65565.19978.461,165924.041,025
Total Common Equity
4,4874,6284,7704,9034,3494,411
Minority Interest
31.7432.4930.06---
Shareholders' Equity
4,5194,6614,8004,9034,3494,411
Total Liabilities & Equity
5,3485,5845,7865,7815,2915,191

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
12.9445.4951.0133.4245.0834.74
Net Cash (Debt)
2,3372,5132,3182,1871,9491,617
Net Cash Growth
11.82%8.39%6.01%12.23%20.49%4.86%
Net Cash Per Share
7.528.157.547.056.325.28
Filing Date Shares Outstanding
315.37308.26307.52312.97309.11306.52
Total Common Shares Outstanding
315.37307.38307.52312.97309.11306.52
Working Capital
2,5052,5682,3132,1921,8951,804
Book Value Per Share
14.2315.0615.5115.6714.0714.39
Tangible Book Value
4,2794,4164,5154,7794,2144,266
Tangible Book Value Per Share
13.5714.3714.6815.2713.6313.92
Buildings
973.78972.8989.32930.62950.07941.9
Machinery
576.42568.49552.53507.9517.78496.86
Construction In Progress
6.778.317.617.0412.79154.51